Duplex real-time RT-PCR assay for detection and subgroup-specific identification of human respiratory syncytial virus.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
09 2019
Historique:
received: 01 03 2019
revised: 06 06 2019
accepted: 07 06 2019
pubmed: 11 6 2019
medline: 4 6 2020
entrez: 11 6 2019
Statut: ppublish

Résumé

Human respiratory syncytial virus (HRSV) is a leading cause of acute respiratory illness in young children worldwide. Reliable detection and identification of HRSV subgroup A and B infections are essential for accurate disease burden estimates in anticipation of licensure of novel HRSV vaccines and immunotherapies. To ensure continued reliability, molecular assays must remain current with evolving virus strains. We have developed a HRSV subgroup-specific real-time RT-PCR (rRT-PCR) assay for detection and subgroup identification using primers and subgroup-specific probes targeting a conserved region of the nucleoprotein gene combined in a single duplex reaction using all genome sequence data currently available in GenBank. The assay was validated for analytical sensitivity, specificity, reproducibility, and clinical performance with a geographically diverse collection of viral isolates and respiratory specimens in direct comparison with an established pan-HRSV rRT-PCR reference test. The assay was sensitive, reproducibly detecting as few as 5-10 copies/reaction of target RNA. The assay was specific, showing no amplification with a panel of 16 other common respiratory pathogens or predicted by in silico primer/probe analysis. The duplex rRT-PCR assay based on the most current available genome sequence data permits rapid, sensitive and specific detection and subgroup identification of HRSV.

Identifiants

pubmed: 31181218
pii: S0166-0934(19)30072-2
doi: 10.1016/j.jviromet.2019.113676
pmc: PMC7172218
pii:
doi:

Substances chimiques

DNA Primers 0
DNA Probes 0
RNA, Viral 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

113676

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

PLoS One. 2010 Nov 30;5(11):e15098
pubmed: 21152047
J Microbiol Methods. 2009 Mar;76(3):316-9
pubmed: 19135484
J Med Virol. 2007 Dec;79(12):1951-8
pubmed: 17935185
J Clin Virol. 2005 Oct;34(2):104-7
pubmed: 16157260
J Clin Virol. 2005 Aug;33(4):341-4
pubmed: 15927526
Int J Mol Sci. 2017 Aug 06;18(8):
pubmed: 28783078
J Clin Microbiol. 2003 Sep;41(9):4378-81
pubmed: 12958272
J Clin Virol. 2004 Oct;31(2):123-9
pubmed: 15364268
J Mol Diagn. 2015 Sep;17(5):505-14
pubmed: 26146130
BMC Pediatr. 2017 Mar 27;17(1):89
pubmed: 28347279
J Virol. 2006 Jan;80(2):975-84
pubmed: 16378999
J Gen Virol. 2003 Nov;84(Pt 11):3115-3120
pubmed: 14573817
PLoS One. 2012;7(12):e51439
pubmed: 23236501
Pediatr Res. 2004 Dec;56(6):914-7
pubmed: 15470202
J Infect Dis. 1997 Apr;175(4):814-20
pubmed: 9086135
J Clin Virol. 2015 May;66:27-32
pubmed: 25866332
J Clin Virol. 2017 Mar;88:21-25
pubmed: 28107671
Curr Opin Pulm Med. 2013 May;19(3):298-304
pubmed: 23425918
Pediatr Infect Dis J. 2017 Aug;36(8):808-810
pubmed: 28383391
J Gen Virol. 1985 Oct;66 ( Pt 10):2111-24
pubmed: 2413163
J Clin Virol. 2013 Jul;57(3):254-60
pubmed: 23608639
PLoS One. 2016 Oct 20;11(10):e0165108
pubmed: 27764220
Mol Cell Probes. 2006 Oct;20(5):311-6
pubmed: 16704921
Methods Mol Biol. 2015;1275:31-56
pubmed: 25697650
J Virol. 1987 Oct;61(10):3163-6
pubmed: 3305988
J Clin Virol. 2006 Jan;35(1):81-3
pubmed: 16002331
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
J Clin Microbiol. 2005 May;43(5):2356-62
pubmed: 15872266
J Gen Virol. 2006 Jul;87(Pt 7):1805-21
pubmed: 16760383
J Virol Methods. 2013 Apr;189(1):15-9
pubmed: 23313883
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
Clin Microbiol Rev. 2008 Oct;21(4):716-47
pubmed: 18854489
J Infect Dis. 1990 Dec;162(6):1283-90
pubmed: 2230258
J Virol Methods. 2013 Aug;191(2):118-21
pubmed: 23583489
J Immigr Minor Health. 2012 Feb;14(1):140-5
pubmed: 21701900
J Infect Dis. 2000 Jun;181(6):1891-6
pubmed: 10837167
J Clin Microbiol. 1987 Aug;25(8):1535-9
pubmed: 3305568

Auteurs

Lijuan Wang (L)

IHRC, Contracting Agency to the Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Pedro A Piedra (PA)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.

Vasanthi Avadhanula (V)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.

Edison L Durigon (EL)

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Ann Machablishvili (A)

National Center for Disease Control and Public Health, Tbilisi, Georgia.

María-Renée López (MR)

Center for Health Studies, Research Institute, Universidad del Valle de Guatemala, Guatemala City, Guatemala.

Natalie J Thornburg (NJ)

Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Teresa C T Peret (TCT)

Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: TPeret@cdc.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH